Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 31, 2018Neurology

Nusinersen in patients older than 7 months with spinal muscular atrophy type 1

View Full Paper
Ask AI
Bookmark
Share

Authors

KAKarolina Aragon‐GawinskaHospital Universitari i Politècnic La FeASAndreea SeferianSorbonne UniversitéADAurore DaronUniversity of Liège

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Aragon‐Gawinska et al. (2018) studied this question.

synapsesocial.com/papers/6a72a2ab87f921057128a0b6https://doi.org/10.1212/wnl.0000000000006281
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The changing natural history of spinal muscular atrophy type 12007 · 323 citations
  2. 2Evaluation of Children with SMA Type 1 Under Treatment with Nusinersen within the Expanded Access Program in Germany2018 · 149 citations
  3. 3Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy2017 · 2,375 citations
  4. 4Natural history of infantile‐onset spinal muscular atrophy2017 · 422 citations
  5. 5Developmental milestones in type I spinal muscular atrophy2016 · 141 citations